Delivery Order SPE2DB22D3016-SPE2DB24FAYH1
Award Date
6/13/24
Potential Completion Date
6/14/24
Potential Value
$9.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,233.58 firm fixed price delivery order contract (SPE2DX15D3008|SPE2DX24F11HV) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of GARDASIL 9 SYRINGE 0.5ML. This delivery order is part of a broader indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies...
The U.S. Defense Logistics Agency (DLA) awarded a $9,366.31 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of GARDASIL 9 syringes. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 syringes. The $9,657.91 firm-fixed-price contract has an ultimate completion date of August 21, 2024. This order is a part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999 through December 2025, for delivering a range of medical commodities to...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,757.64 to provide GARDASIL 9 vaccine syringes. The contract has a completion date of February 5, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not associated with any set-aside designation. This contract is part of a larger indefinite delivery contract (IDC) valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $102,501.72 to Amerisourcebergen Drug Corp, the prime contractor, to provide GARDASIL 9 vaccine syringes. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 syringes (0.5 mL). The $4,863.64 firm fixed-price contract has an ultimate completion date of August 15, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a range of medical commodities to support military treatment...
The U.S. Defense Logistics Agency (DLA) awarded a $12,548 delivery order contract to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 pharmaceutical syringes. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has a firm...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of GARDASIL 9 syringes, 0.5 mL, to the U.S. government. The contract has a ceiling value of $13,569.74 and a completion date of April 30, 2024. It was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide GARDASIL 9 (0.5mL syringe) vaccines. The delivery order, valued at $7,842.50, has a firm fixed price and an ultimate completion date of May 17, 2024. It is not a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to...
This federal contract award is for the delivery of GARDASIL 9 syringes (0.5 ml) to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies. The contract, valued at $15,773.30, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and...